Table 1.
Construct | % targeted myotubes* | No. of myotubes analyzed |
---|---|---|
GFP-α1S (ref. 11) | 58 | 967 |
GFP-I⋅II | 0 | 361 |
III⋅IV | 0 | 362 |
GFP-I⋅II + III⋅IV | 73 | 735 |
GFP-I⋅II⋅tail | 0 | 799 |
GFP-I⋅II⋅tail + III⋅IV | 28 | 321 |
III⋅IV⋅βin | 0 | 400 |
GFP-I⋅II + III⋅IV⋅βin | 2 | 600 |
Myotubes were classified as “targeted” if any region of the myotubes displayed the characteristic clustered immunolabeling pattern (see Fig. 1) colocalized with RyR1 label, which is indicative of triad labeling. The remainder represents myotubes in which the construct was expressed but not colocalized with RyR1-positive clusters.